Current filters:

Clear current filters  or Add more filters

View Option

Results 31-40 of 48 (Search time: 0.067 seconds).

  Plasma Visfatin Concentration Is a Marker of an Atherogenic Metabolic Profile (Journal article)

  The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia (Journal article)

  The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterolemia (Journal article)

  Plasma triglyceride levels and body mass index values are the most important determinants of pre beta-1 HDL concentrations in patients with various types of primary dyslipidemia (Journal article)

  Premature Atherosclerosis in Non-Transfusion-Dependent beta-Thalassemia Intermedia (Journal article)

  The Effects of Hypolipidemic Treatment on Lipoprotein-Associated Phospholipase A2 in Patients with Mixed Hyperlipidemia (Journal article)

  Apolipoprotein A-I peptide models as probes to formulate potential inhibitors of the low-density lipoprotein oxidation (Journal article)

  Association of Serum Paraoxonase-1 With Platelet Responsiveness to Clopidogrel in Patients With Acute Coronary Syndromes (Journal article)

  High doses of rosuvastatin are superior to low doses of rosuvastatin plus fenofibrate or n-3 fatty acids in mixed dyslipidemia (Journal article)

  Combining rosuvastatin with sartans of different peroxisome proliferator-activated receptor-gamma activating capacity is not associated with different changes in low-density lipoprotein subfractions and plasma lipoprotein-associated phospholipase A (Journal article)